Members |
targetComponentId |
Avulsion of eye |
Traumatic enucleation of eye |
Axenfeld's anomaly |
Axenfeld anomaly |
Axenfeld's anomaly |
Posterior embryotoxon (disorder) |
Axilla |
Entire axillary region |
Axilla |
Entire axillary fossa (body structure) |
Axilla |
Structure of axillary fossa (body structure) |
Axilla |
Entire axillary fossa (body structure) |
Axilla |
Entire axillary region |
Axilla |
Axillary region structure |
Axilla |
Structure of axillary fossa (body structure) |
Axilla |
Axillary region structure |
Axilla structure |
Axillary region structure |
Axilla structure |
Structure of axillary fossa (body structure) |
Axillary artery and its branches |
Structure of axillary artery |
Axillary artery and its branches |
Entire axillary artery |
bålens axillarlinje |
Posterior axillary line structure |
bålens axillarlinje |
Anterior axillary line structure |
Axillary vein and its tributaries |
Structure of axillary vein |
Axillary vein and its tributaries |
Entire axillary vein |
Axillary-femoral arterial bypass |
Superficial axillofemoral vascular bypass (procedure) |
Axillary-femoral arterial bypass |
Axillary-femoral arterial bypass (procedure) |
axitinib 1 mg, tablett |
Product containing precisely axitinib 1 milligram/1 each conventional release oral tablet (clinical drug) |
axitinib 5 mg, tablett |
Axitinib 5 mg oral tablet |
Ayalas sjukdom |
Langerhans cell histiocytosis |
azatadinmaleat 500 mikrogram/5 ml, sirap |
Azatadine maleate 100 microgram/mL oral solution |
Azathioprine [immunosuppressant] |
Azathioprine adverse reaction |
Azathioprine [immunosuppressant] |
Product containing azathioprine (medicinal product) |
azoospermi orsakad av cytostatika och/eller strålning |
Azoospermia caused by chemotherapy (disorder) |
azoospermi orsakad av cytostatika och/eller strålning |
Azoospermia caused by radiation (disorder) |
Azospirillumart |
Azospirillum |
Azure flycatcher |
Myiagra azureocapilla (organism) |
Azygos vein and its tributaries |
Structure of azygous vein |
Azygos vein and its tributaries |
Entire azygous vein |
B |
Lymphoma staging symptom status B (tumor staging) |
B |
Upper case Roman letter B (qualifier value) |
B-K mole (nevus) syndrome |
B-K mole (nevus) syndrome |
B-K mole (nevus) syndrome |
Epidermal naevus syndrome |
B12 deficiency anaemia (& other) |
Megaloblastic anemia due to vitamin B>12< deficiency |
BCG injection used in malignancy |
Bacillus Calmette-Guerin antigen-containing product |
BCG vaccine |
Bacillus Calmette-Guerin antigen-containing vaccine product |
BCG vaccine |
Bacillus Calmette-Guerin antigen-containing vaccine product |
BCG vaccine |
Bacillus Calmette-Guerin antigen-containing vaccine product |
BD Pen device |
Injection device |
BD Ultra Pen 1.5mL 1 unit device |
Injection device |
BD Ultra Pen 3.0mL 1 unit device |
Injection device |
BFN-3187-virus |
Gray Lodge hapavirus (organism) |
BM-Hopitest urine testing strip |
Urinalysis test strips (physical object) |
BM-Test-GP urine test strip |
Urinalysis test strips (physical object) |
BP abnorm,but not diagnost.[D] |
Elevated blood-pressure reading without diagnosis of hypertension |
Babesiaart |
Babesia |
Babinski sign |
Extensor plantar response finding |
Babinski sign |
Extensor plantar response |
Baby buggy |
Child conveyance (physical object) |
Baby buggy |
Pram |
Baby buggy |
Infant conveyance |
diverse riskfaktorer för spädbarn |
Risk factor (observable entity) |
Bacillus Calmette-Guerin used in malignancy |
Bacillus Calmette-Guerin antigen-containing product |
Bacillusart |
Bacillus |
Back dislocation NOS |
Dislocation of joint |
Back injury |
Injury of back |
Back pain |
Vertebrogenic pain syndrome (disorder) |
Back pain |
Backache |
Back pain |
Disorder characterized by back pain (disorder) |
Back pain |
Backache |
Back pain |
Backache |
Back pain |
Backache |
Back pain |
Disorder characterized by back pain (disorder) |
Back pain |
Vertebrogenic pain syndrome (disorder) |
Back pain (finding) |
Backache |
Back pain |
Disorder characterized by back pain (disorder) |
Back pain |
Vertebrogenic pain syndrome (disorder) |
Back performance-feedback physical therapy system, home-use |
Back performance-feedback physical therapy system |
Back performance-feedback physical therapy system, professional |
Back performance-feedback physical therapy system |
ryggregion |
Regional back structure |
Backache |
Backache |
Backache |
Disorder characterized by back pain (disorder) |
Backache (disorder) |
Backache |
Backache |
Backache |
Backache symptom |
Vertebrogenic pain syndrome (disorder) |
Backache symptom |
Backache |
Backache symptom |
Disorder characterized by back pain (disorder) |
Backache symptom NOS |
Backache |
Backache symptom NOS |
Backache |
Baclofen 10mg/5mL |
Product containing precisely baclofen 2 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Baclofen 10mg/5mL solution |
Product containing precisely baclofen 2 milligram/1 milliliter conventional release solution for injection (clinical drug) |
baklofen 2 mg/ml, injektionsvätska, lösning, ampull 5 ml |
Product containing precisely baclofen 2 milligram/1 milliliter conventional release solution for injection (clinical drug) |
baklofen 5 mg/5 ml, sockerfri vätska |
Baclofen 1 mg/mL oral solution |
Bacteria |
Domain Bacteria (organism) |
Bacteria |
Bacterium |
stängelcell |
Domain Bacteria stalk cell detected |
bakteriecell |
Domain Bacteria (organism) |
bakteriellt antigen från odlad koloni |
Bacteria antigen |
Bacterial diseases (& [excl TB]) |
Bacterial infectious disease |
Bacterial endocarditis (& [acute] or [subacute]) |
Bacterial endocarditis |
Bacterial endocarditis (& [acute] or [subacute]) |
Acute and subacute bacterial endocarditis |
Bacterial endocarditis |
Infective endocarditis |
Bacterial endocarditis |
Bacterial endocarditis |
bakteriell serotyp |
Bacterium |
bakterievaccin |
Bacteria antigen-containing vaccine product |
Bacterial vaccine poisoning NOS |
Adverse reaction to bacterial vaccine |
Bacterial vaginosis |
Gardnerella vaginitis (disorder) |